✦ LIBER ✦

741 Safety, tolerability and antiviral activity of pradefovir mesylate in patients with chronic hepatitis B virus infection: 48-week analysis of a phase 2 study

✍ Scribed by K.S. Lee; S.G. Lim; W.L. Chuang; S.G. Hwang; M. Cho; M.Y. Lai; Y.C. Chao; T.T. Chang; K.H. Han; C.M. Lee; S.H. Um; J.E. Yeon; S.S. Yang; E.K. Teo; C.Y. Peng; H.H. Lin; T.I. Huo; T. Nguyen; T.Y. Chen; K.Q. Hu; Y. Xu; J.Z. Sullivan-Bólyai; K.S. Lee

Book ID: 117375017
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 125 KB
Volume: 44
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(06)80742-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

963 SAFETY AND A ANTIVIRAL ACTIVITY OF A

963 SAFETY AND A ANTIVIRAL ACTIVITY OF A MONOTHERAPY WITH A MP-424 FOR 24 WEEKS IN NAIVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 1B INFECTION

✍ I. Ozeki 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

1152 A phase II study in China of the sa

1152 A phase II study in China of the safety & antiviral activity of entecavir in adults with chronic hepatitis B infection

✍ YAO, G; XU, D; WANG, B; ZHOU, X; LEI, B; ZHANG, D; XU, D; LIU, J; MACDONALD, L 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Clinical trial: a phase II, randomized s

Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B

✍ S. G. LIM; N. LEUNG; H. W. L. HANN; G. K. K. LAU; C. TREPO; H. MOMMEJA-MARIN; C. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB

Antiviral activity, dose–response relati

Antiviral activity, dose–response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial

✍ Michiko Shindo; Kazuaki Chayama; Satoshi Mochida; Joji Toyota; Eiichi Tomita; Hi 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 242 KB

P.113 Anti-viral activity, histologic im

P.113 Anti-viral activity, histologic improvement and safety of entecavir in Japanese adult nucleoside-analogue naive patients with chronic hepatitis B infection: a phase 2 clinical trial

✍ K. Takaguchi; K. Kita; H. Ikeda; O. Yokosuka; M. Kawaguchi; K. Sakaguchi; T. Ser 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 141 KB